AMGN vs CPHI · P/E 24, rev $36.75B vs rev $4.1M
Amgen Inc (AMGN) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the AMGN and CPHI stock pages for the full models.
Not investment advice.